Digitalni repozitorij raziskovalnih organizacij Slovenije

Izpis gradiva
A+ | A- | Pomoč | SLO | ENG

Naslov:Proteomic analysis identifying proteins relevant for treatment success following experimental neonatal inflammationsensitized hypoxia-ischemia
Avtorji:ID Burkard, Hannah (Avtor)
ID Osredkar, Damjan (Avtor)
ID Maes, Elke (Avtor)
ID Bernis, Maria E. (Avtor)
ID Bremer, Anna-Sophie (Avtor)
ID Zweyer, Margit (Avtor)
ID Dowling, Paul (Avtor)
ID Ohlendieck, Kay (Avtor)
ID Thoresen, Marianne (Avtor)
ID Sabir, Hemmen (Avtor)
Datoteke:.pdf PDF - Predstavitvena datoteka, prenos (6,20 MB)
MD5: 137058DD24AE691157938E0D588CEB26
 
URL URL - Izvorni URL, za dostop obiščite https://www.nature.com/articles/s41390-025-04097-8
 
Jezik:Angleški jezik
Tipologija:1.01 - Izvirni znanstveni članek
Organizacija:Logo UKC LJ - Univerzitetni klinični center Ljubljana
Povzetek:BACKGROUND: Understanding the mechanisms of injury following neonatal hypoxic-ischemic encephalopathy (HIE) is a major goal in neonatal research. HIE can have severe effects on cognitive and motor development in newborns, including an increased risk of death. As the incidence is 10–20 times higher in low- and middle-income countries compared to developed countries, the interest in a therapy exists worldwide. Therapeutic hypothermia (HT) is the only effective treatment after HIE. However, TH is not universally effective, particularly in cases of inflammation-sensitized hypoxia-ischemia (HI); it provides limited benefit. METHODS: To identify proteins that may contribute to the reduced efficacy of HT in the case of pre-HI inflammation sensitization, the proteomic profiles of animals subjected to HI and HT combined with lipopolysaccharide (LPS) were analyzed via liquid chromatography mass spectrometry (LC-MS/MS). RESULTS: We identified proteins that potentially support the efficacy of HT and those that prevent the success of the therapy in the neonatal rat model of inflammation-sensitized HI. CONCLUSION: This study represents a step forward in identifying proteins related to the efficacy of HT following inflammationsensitized HI.
Status publikacije:Objavljeno
Verzija publikacije:Objavljena publikacija
Leto izida:2026
Št. strani:str. 1591–1601
Številčenje:Vol. 99
PID:20.500.12556/DiRROS-28060 Novo okno
UDK:616-053.2
ISSN pri članku:0031-3998
DOI:10.1038/s41390-025-04097-8 Novo okno
COBISS.SI-ID:237965315 Novo okno
Datum objave v DiRROS:09.03.2026
Število ogledov:137
Število prenosov:88
Metapodatki:XML DC-XML DC-RDF
:
Kopiraj citat
  
Objavi na:Bookmark and Share


Postavite miškin kazalec na naslov za izpis povzetka. Klik na naslov izpiše podrobnosti ali sproži prenos.

Gradivo je del revije

Naslov:Pediatric research
Skrajšan naslov:Pediatr. res.
Založnik:Williams & Wilkins Co.
ISSN:0031-3998
COBISS.SI-ID:5639175 Novo okno

Gradivo je financirano iz projekta

Financer:Drugi - Drug financer ali več financerjev
Številka projekta:U3
Naslov:Projekt DEAL

Licence

Licenca:CC BY 4.0, Creative Commons Priznanje avtorstva 4.0 Mednarodna
Povezava:http://creativecommons.org/licenses/by/4.0/deed.sl
Opis:To je standardna licenca Creative Commons, ki daje uporabnikom največ možnosti za nadaljnjo uporabo dela, pri čemer morajo navesti avtorja.

Sekundarni jezik

Jezik:Slovenski jezik
Ključne besede:hipoksija, beljakovine, novorojenčki, proteomika


Nazaj